US FDA Panel Divided In Support Of Ipsen’s Rare Bone Disorder Drug Palovarotene

 
• By Brenda Sandburg
  
Bone disorder
Drug to treat rare bone growth disorder gets mixed review from FDA advisory committee. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers